Azienda Ospedaliero Universitaria Di Sassari — Clinical Trial Site

43 Registered trials

21 Currently recruiting

Organisation

Azienda Ospedaliero Universitaria Di Sassari

Location

Sassari, Italy

Identifier

ORG-100030363

Address

Viale San Pietro 10, 07100, Italy

Departments

039023: U.O.C. Oncologia Medica
2521:U.O.C. Cardiologia Clinica e Interventistica
Cardio Toraco-Vascolare
Cardiologia
Cardiology
Clinical and Interventional Cardiology Unit
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
Dipartimento di Medicina Clinica e Sperimentale - UOC EMATOLOGIA
Ginecologia
medical director Ospedale Civile SS. Annunziata
Medical Oncology
Neurological clinic
Ospedale Civile SS. Annunziata - UOC Oncologia Medica
Pneumologia Clinica e Interventistica
Pneumology Clinic
Sc Cardiologia Clinica e Interventistica
SC Cardiologia Clinica ed Interventistica
SC di Malattie Infettive e Tropicali
SC Malattie Infettive e Tropicali
SC Pneumologia Clinica e Interventistica
SC Pneumological and Interventional Clinic
SS Cardiologia Clinica e Interventistica
U.O. Neuropsichiatria Infantile
U.O. Oncologia Medica
U.O.C. di Oncologia Medica
U.O.C. Oftalmologia
U.O.C. Oncologia Medica
UOC Cardiologica Clinica ed Interventistica
UOC Oncologia Medica
UOC Oncologica Medica

Clinical trials at this site (43)

Search interface

A multicentre, prospective, open-label, non-comparative study to evaluate menstrual bleeding typology, tolerability, and compliance during a… Pending

2024-519403-10-00 Female contraception. 6
OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending

2025-520554-11-00 Cardiovascular Disease 5
A Long-term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of Pulmonary Hypertension Associated with In… Pending

2025-521769-29-00 Pulmonary Hypertension Associated with Interstitial Lun 5
A Study to Evaluate the Long-term Safety and Tolerability of Admilparant in Participants with Pulmonary Fibrosis. Pending

2025-522373-10-00 Progressive pulmonary fibrosis and Idiopathic pulmonary 5
ARMYDA - 10 study Pending

2025-523977-40-00 non-ST-elevation myocardial infarction (NSTEMI); unstab 6
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1) Pending

2025-524040-35-00 Severe uncontrolled asthma 5
A study for adolescents who are depressed and thinking of suicide Recruiting

2024-518615-19-00 Major Depressive Disorder 5 2026-04-22
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Trepostini… Recruiting

2025-521558-40-00 Pulmonary Hypertension Associated with Interstitial Lun 5 2026-02-12
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast C… Recruiting

2024-515445-42-00 Node-positive, Estrogen Receptor-positive, HER2-negativ 5 2025-03-24
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
ROMANCE Recruiting

2025-521319-38-00 metastatic colorectal cancer 4 2026-03-11
Phase II randomized trial of XELOX plus DoSTARlimab versus XELOX alone as Consolidation Treatment after Standard Chemoradiation in pMMR/MSS … Recruiting

2024-519798-20-00 pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LAR 4 2026-01-15
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis Recruiting

2024-515979-35-00 Generalized Myasthenia Gravis 5 2025-11-13
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) Recruiting

2024-513613-12-00 Part A: Healthy volunteers (Part A is not applicable to 9 2025-09-18
A Trial to Test How AZD0780 Affects Serious Heart, Stroke, or Vascular Problems in Patients with Heart, Stroke or Vascular Disease or at Hig… Recruiting

2025-520519-14-00 Atherosclerotic Cardiovascular Disease 5 2025-09-03
RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, TWO-ARMS, MULTICENTER, POST AUTHORIZATION EFFICACY AND SAFETY STUDY (PAES) TO CONFIRM AND COLL… Recruiting

2024-512937-34-00 RECURRENT LOWER RESPIRATORY TRACT INFECTIONS (RLRTIS). 6 2025-08-06
CAPRI-3 Phase 3 clinical study to evaluate the use of continuing cetuximab treatment beyond first line progression in molecular selected met… Recruiting

2024-519322-20-00 metastatic colorectal cancer 5 2025-07-21
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmona… Recruiting

2024-517458-90-00 Chronic obstructive pulmonary disease (COPD) 5 2025-06-06
Continued PD-L1 inhibition with atezolizumab with rechallenge chemotherapy in patients with sensitive relapse SCLC progressing on first-line… Recruiting

2024-511945-20-00 patients affected by small cell lung cancer (SCLC) 4 2025-01-24
A phase II randomized clinical study of the combination of avelumab plus cetuximab as rechallenge strategy in pre-treated RAS/BRAF wild type… Recruiting

2024-519481-44-00 colorectal metastatic cancer 4 2025-01-08
Phase III study in mCRC patients with RAS/BRAF wild type tissue and RAS/BRAF mutated in LIquid BIopsy to compare in first-line therapy FOLFI… Recruiting

2024-517863-22-00 Study population consists in patients with a diagnosis 5 2024-12-01
Randomized phase 3 study of intermittent or continuous Panitumumab plus FOLFIRI for first-line treatment of patients with unresectable left … Recruiting

2023-509551-14-00 Unresectable left sided RAS/B-RAF wild-type metastatic 5 2024-06-12
A study to assess efficacy of citicoline on visual field preservation in patients with glaucoma Recruiting

2022-502273-42-00 Glaucoma 5 2023-11-08
Comparison between single and dual therapy with drugs that inhibits platelet aggregation in patient undergoing the percutaneous left atrial … Recruiting

2024-515361-34-00 Patients with atrial fibrillation undergoing percutaneo 6 2021-10-13